Weekly Top Biotech and Medical Business Articles
by H.S. Ayoub
BioHealth Investor.com
The following articles were the most popular at BioHealth Investor for the week of May 5 - May 11.
This list can also be found on the right navigation bar of the blog during the week.
1. Dendreon Gets Complete Response Letter
2. When a $0 copay is too high
3. Does FDA Need a Statutory Path to Approve Follow-on Biologics?
4. Credibility and Prosperity in Biotech
5. Protesters at BIO2007 Fear Unintended Consequences
Last Week's Top Articles
____________________
BioHealth Investor.com
The following articles were the most popular at BioHealth Investor for the week of May 5 - May 11.
This list can also be found on the right navigation bar of the blog during the week.
1. Dendreon Gets Complete Response Letter
2. When a $0 copay is too high
3. Does FDA Need a Statutory Path to Approve Follow-on Biologics?
4. Credibility and Prosperity in Biotech
5. Protesters at BIO2007 Fear Unintended Consequences
Last Week's Top Articles
____________________
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home